Literature DB >> 20493772

Targeting inflammation using selective glucocorticoid receptor modulators.

Karolien De Bosscher1, Guy Haegeman, Dirk Elewaut.   

Abstract

Glucocorticoids have been used since several decades in a variety of diseases in view of their potent anti-inflammatory properties. Nevertheless, the widespread use of glucocorticoids is hampered by the risk of side effects. Because the effects of glucocorticoids are mediated at large through interaction with the glucocorticoid receptor, which results in anti-inflammatory effects as well as side effects, much attention has been given to understanding the molecular regulation. Over the past decade, remarkable progress has been made in the mechanisms mediating glucocorticoid receptor dependent gene regulation. In this review we provide an overview of recent progress in understanding the mode of action of glucocorticoids and novel strategies to dissociate anti-inflammatory from metabolic side effects. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20493772     DOI: 10.1016/j.coph.2010.04.007

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  53 in total

1.  Compound A, a selective glucocorticoid receptor agonist, inhibits immunoinflammatory diabetes, induced by multiple low doses of streptozotocin in mice.

Authors:  T Saksida; M Vujicic; I Nikolic; I Stojanovic; G Haegeman; S Stosic-Grujicic
Journal:  Br J Pharmacol       Date:  2014-11-24       Impact factor: 8.739

2.  Topical Mineralocorticoid Receptor Blockade Limits Glucocorticoid-Induced Epidermal Atrophy in Human Skin.

Authors:  Eve Maubec; Cédric Laouénan; Lydia Deschamps; Van Tuan Nguyen; Isabelle Scheer-Senyarich; Anne-Catherine Wackenheim-Jacobs; Maud Steff; Stéphanie Duhamel; Sarah Tubiana; Nesrine Brahimi; Stéphanie Leclerc-Mercier; Béatrice Crickx; Claudine Perret; Selim Aractingi; Brigitte Escoubet; Xavier Duval; Philippe Arnaud; Frederic Jaisser; France Mentré; Nicolette Farman
Journal:  J Invest Dermatol       Date:  2015-02-10       Impact factor: 8.551

Review 3.  Glucocorticoid sensitivity in health and disease.

Authors:  Rogier A Quax; Laura Manenschijn; Jan W Koper; Johanna M Hazes; Steven W J Lamberts; Elisabeth F C van Rossum; Richard A Feelders
Journal:  Nat Rev Endocrinol       Date:  2013-10-01       Impact factor: 43.330

4.  Metastasized lung cancer suppression by Morinda citrifolia (Noni) leaf compared to Erlotinib via anti-inflammatory, endogenous antioxidant responses and apoptotic gene activation.

Authors:  Swee-Ling Lim; Noordin M Mustapha; Yong-Meng Goh; Nurul Ain Abu Bakar; Suhaila Mohamed
Journal:  Mol Cell Biochem       Date:  2016-04-22       Impact factor: 3.396

Review 5.  The multiple facets of glucocorticoid action in rheumatoid arthritis.

Authors:  Ulrike Baschant; Nancy E Lane; Jan Tuckermann
Journal:  Nat Rev Rheumatol       Date:  2012-10-09       Impact factor: 20.543

6.  Context-dependent cooperation between nuclear factor κB (NF-κB) and the glucocorticoid receptor at a TNFAIP3 intronic enhancer: a mechanism to maintain negative feedback control of inflammation.

Authors:  Mohammed O Altonsy; Sarah K Sasse; Tzu L Phang; Anthony N Gerber
Journal:  J Biol Chem       Date:  2014-02-05       Impact factor: 5.157

7.  Antcin A, a steroid-like compound from Antrodia camphorata, exerts anti-inflammatory effect via mimicking glucocorticoids.

Authors:  Yi-ching Chen; Ya-lin Liu; Feng-yin Li; Chi-I Chang; Sheng-yang Wang; Kuo-yang Lee; Shun-lai Li; Yi-peng Chen; Tzyy-rong Jinn; Jason T C Tzen
Journal:  Acta Pharmacol Sin       Date:  2011-05-23       Impact factor: 6.150

Review 8.  Novel adjunctive therapies for the treatment of tuberculosis.

Authors:  A A Ordonez; M Maiga; S Gupta; E A Weinstein; W R Bishai; S K Jain
Journal:  Curr Mol Med       Date:  2014-03       Impact factor: 2.222

Review 9.  Genomic and non-genomic effects of glucocorticoids: implications for breast cancer.

Authors:  Irma B Mitre-Aguilar; Alberto J Cabrera-Quintero; Alejandro Zentella-Dehesa
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

10.  Identification of a selective glucocorticoid receptor modulator that prevents both diet-induced obesity and inflammation.

Authors:  José K van den Heuvel; Mariëtte R Boon; Ingmar van Hengel; Emma Peschier-van der Put; Lianne van Beek; Vanessa van Harmelen; Ko Willems van Dijk; Alberto M Pereira; Hazel Hunt; Joseph K Belanoff; Patrick C N Rensen; Onno C Meijer
Journal:  Br J Pharmacol       Date:  2016-04-24       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.